A transcriptional progression model for head and neck cancer.
Patrick K. Ha(University of California, San Francisco), Joseph A. Califano(University of California San Diego), William H. Westra(Mount Sinai Hospital), Marianna Zahurak(Bloomberg (United States)), Nicole Benoit, David Sidransky(University of Baltimore), Robert Yochem, James J. Sciubba(Johns Hopkins University), Jonathan Pevsner(Kennedy Krieger Institute)
PubMed
August 1, 2003
Cited by 125
Related Papers
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in <i>NOTCH1</i>
|Science|2011|1.7k
A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
|Nature Medicine|2018|1k
Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
|Nature Genetics|1995|646